<?xml version="1.0" encoding="UTF-8"?>

<Requirements xmlns="http://hl7.org/fhir">
  <id value="F-PIL-28"/>
  <text>
    <status value="extensions"/><div xmlns="http://www.w3.org/1999/xhtml">

    <div style="display: inline-block;
                background-color: #d9e0e7; 
                padding: 6px; 
                margin: 4px; 
                border: 1px solid #8da1b4;
                border-radius: 5px; 
                line-height: 60%;
                width: 100%;">
        
            <p style="padding-bottom: 0px; margin: 0px;">
                <b>ID</b>: F-PIL-28
            </p>
        
        

        
        
            <p style="padding-bottom: 0px; margin: 0px;">
                <b>Publisher</b>: HL7 Europe
            </p>
        
        
            <table style="width: 100%;" class="grid">
                <tr style="background-color: #333f4c; color: #ffffff;">
                    <th style="text-align: center;"><b>Contact Name</b></th>
                    <th style="text-align: center;"><b>Contact Points</b></th>
                </tr>
                
                        <tr style="background-color: #ffffff;">
                        <td> HL7 Europe  </td>
                        <td>
                            <ul>
                                
                                    <li>
                                    
                                        <a href="https://www.hl7.eu">https://www.hl7.eu</a>
                                    
                                    </li>
                                
                            </ul>
                        </td>
                    </tr>
                
            </table>
        
        
        
            <p style="padding-bottom: 0px; margin: 0px;">
                <b>Description</b>:
            </p>
            <div><p>Type of biopsy shall be provided at time of biopsy with class 0 for initial or 2 for repeated.</p>
</div>
        
        
        
        
        
            <p style="padding-bottom: 0px; margin: 0px;">
                <b>Purpose</b>:
            </p>
            <div><p>FLUTE specific requirements for FLUTE pilot studies and the platform are outlined based on discussions with stakeholders participating in the case studies, in particular representatives of technical partners participating in WP5 (Quibim) and medical researchers from the three participating hospitals CHUL, IRST and VHIR, which also act as data owners.</p>
</div>
        
        
        
            <p style="padding-bottom: 0px; margin: 0px;">
                <b>Copyright Label</b>: Federated Learning and mUlti-party computation Techniques for prostatE cancer
            </p>
        

        

        
        
        
    </div><br/>

    <div style="display: inline-block;
        padding: 6px; 
        margin: 4px; 
        width: 100%;">
        
            <p style="padding-bottom: 0px; margin: 0px;">
                <b>Statements</b>: 
            </p>
            
                <blockquote>
                    <p style="padding-bottom: 0px; margin: 0px;"><b>ID</b>: F-PIL-28</p>
                    
                        <p style="padding-bottom: 0px; margin: 0px;">
                            <b>Label</b>: Type of biopsy SHALL be provided at time of biopsy with class 0 for initial or 2 for repeated.
                        </p>
                    
                    
                    
                        <p style="padding-bottom: 0px; margin: 0px;"><b>Sources</b>:</p>
                        <ul>
                            
                                <li>
                                    HL7 Europe
                                </li>
                            
                        </ul>
                    
                    <table style="width: 100%;">
                        <tr style="background-color: #333f4c; color: #ffffff;">
                            
                            <th><b>Conformance</b></th> 
                            <th><b>Requirement</b></th>
                            
                            
                            
                        </tr>
                        <tr style="background-color: #ffffff;">
                            
                            
                                <td>
                                    
                                        <code>SHALL</code>   
                                    
                                </td>
                            
                            <td><div><p>be provided at time of biopsy with class 0 for initial or 2 for repeated</p>
</div></td>
                            
                            
                            
                        </tr>
                    </table>
                </blockquote>
            
        
    </div>
</div>
  </text>
  <url value="https://flute.com/Requirements/F-PIL-28"/>
  <version value="0.1.0"/>
  <name value="F_PIL_28"/>
  <title value="F-PIL-28"/>
  <status value="draft"/>
  <date value="2023-10-25T10:31:30.239Z"/>
  <publisher value="HL7 Europe"/>
  <contact>
    <name value="HL7 Europe"/>
    <telecom>
      <system value="url"/>
      <value value="https://www.hl7.eu"/>
    </telecom>
  </contact>
  <description value="Type of biopsy shall be provided at time of biopsy with class 0 for initial or 2 for repeated."/>
  <purpose value="FLUTE specific requirements for FLUTE pilot studies and the platform are outlined based on discussions with stakeholders participating in the case studies, in particular representatives of technical partners participating in WP5 (Quibim) and medical researchers from the three participating hospitals CHUL, IRST and VHIR, which also act as data owners."/>
  <copyright value="HL7 Europe"/>
  <copyrightLabel value="Federated Learning and mUlti-party computation Techniques for prostatE cancer"/>
  <statement>
    <key value="F-PIL-28"/>
    <label value="Type of biopsy SHALL be provided at time of biopsy with class 0 for initial or 2 for repeated."/>
    <conformance value="SHALL"/>
    <requirement value="be provided at time of biopsy with class 0 for initial or 2 for repeated"/>
    <source>
      <display value="HL7 Europe"/>
    </source>
  </statement>
</Requirements>